跳至主要内容
临床试验/CTRI/2013/05/003685
CTRI/2013/05/003685Other3 期

EFFICACY OF METFORMIN IN PREVENTING OLANZAPINE INDUCED METABOLIC ABNORMALITIES IN SCHIZOPHRENIC PATIENTS â?? A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY.

Dr Urmila Anil Kagal0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
Other
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex aged between 18 and 65 years suffering from first episode schizophrenia as diagnosed by the Diagnostic and Statistical Manual of Mental disorders IV (DSM IV) criteria.

排除标准

  • a. Patients with pre-existing obesity. (Body mass index >30kg/m2 and/or waist circumference >= 90cm and >=80cm in males and females respectively).
  • b. Patients with a known diagnosis of type 1 or type 2 diabetes mellitus.
  • c. Patients suffering from anorexia nervosa, bulimia nervosa or neoplastic disease.
  • d. Patients with a history of alcohol dependence.
  • e. Patients suffering from any major endocrine disorder.
  • f. Patient on treatment for any major medical or surgical illness.
  • g. Pregnant and lactating women.
  • h. Non complying patients.

研究者

发起方
Dr Urmila Anil Kagal

相似试验